London, Nov. 8 (Reuters): British doctors said today they plan to inject stem cells into heart attack patients in an experimental treatment aimed at preventing heart failure and death.

About 100 patients will receive stem cells from their own bone marrow — or a placebo — within five hours of a heart attack in the study, expected to begin early next year.

“We are hoping that the patients will have an increased quality of life six months after the procedure,” said Professor John Martin, of University College, London, who will conduct the trial.

Stem cells are master cells that can turn into any cell or tissue type. Scientists believe they could act as a type of repair system and offer new treatments for illnesses ranging from heart disease and diabetes to Alzheimer’s and multiple sclerosis.

Embryonic stem cells have the most potential but their use is controversial because they are derived from early embryos. Adult stem cells have a more limited range. But cells taken from the patients themselves overcome the ethical concerns and reduce the risk of their being rejected by the body.

“All other studies have put cells into the heart in small groups of patients several days or weeks after the heart attack,” Martin said.

The British study will combine the normal treatment for a heart attack, along with the stem cell therapy.

The scientists believe that if the therapy is delivered quickly after an attack it can stop the damage to the heart. Earlier stem cell studies have tried to repair the heart after it has been damaged.